Cargando…
Tocilizumab in COVID-19: Is the Temptation Worthwhile?
How to cite this article: Gupta S, Tomar DS. Tocilizumab in COVID-19: Is the Temptation Worthwhile? Indian J Crit Care Med 2021;25(3): 247–248.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Jaypee Brothers Medical Publishers
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991758/ https://www.ncbi.nlm.nih.gov/pubmed/33790498 http://dx.doi.org/10.5005/jp-journals-10071-23750 |
| _version_ | 1783669234530779136 |
|---|---|
| author | Gupta, Sachin Tomar, Deeksha S |
| author_facet | Gupta, Sachin Tomar, Deeksha S |
| author_sort | Gupta, Sachin |
| collection | PubMed |
| description | How to cite this article: Gupta S, Tomar DS. Tocilizumab in COVID-19: Is the Temptation Worthwhile? Indian J Crit Care Med 2021;25(3): 247–248. |
| format | Online Article Text |
| id | pubmed-7991758 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Jaypee Brothers Medical Publishers |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79917582021-03-30 Tocilizumab in COVID-19: Is the Temptation Worthwhile? Gupta, Sachin Tomar, Deeksha S Indian J Crit Care Med Editorial How to cite this article: Gupta S, Tomar DS. Tocilizumab in COVID-19: Is the Temptation Worthwhile? Indian J Crit Care Med 2021;25(3): 247–248. Jaypee Brothers Medical Publishers 2021-03 /pmc/articles/PMC7991758/ /pubmed/33790498 http://dx.doi.org/10.5005/jp-journals-10071-23750 Text en Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd. © Jaypee Brothers Medical Publishers. 2021 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Editorial Gupta, Sachin Tomar, Deeksha S Tocilizumab in COVID-19: Is the Temptation Worthwhile? |
| title | Tocilizumab in COVID-19: Is the Temptation Worthwhile? |
| title_full | Tocilizumab in COVID-19: Is the Temptation Worthwhile? |
| title_fullStr | Tocilizumab in COVID-19: Is the Temptation Worthwhile? |
| title_full_unstemmed | Tocilizumab in COVID-19: Is the Temptation Worthwhile? |
| title_short | Tocilizumab in COVID-19: Is the Temptation Worthwhile? |
| title_sort | tocilizumab in covid-19: is the temptation worthwhile? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991758/ https://www.ncbi.nlm.nih.gov/pubmed/33790498 http://dx.doi.org/10.5005/jp-journals-10071-23750 |
| work_keys_str_mv | AT guptasachin tocilizumabincovid19isthetemptationworthwhile AT tomardeekshas tocilizumabincovid19isthetemptationworthwhile |